louisakewell, Author at European Medical Journal - Page 124 of 153

EMJ

The Hidden Consequences of Antibiotic Overuse

CONSEQUENCES of long-term antibiotic use may be even more extensive than previously thought; this is according to research that investigates…

EMJ

Why You Shouldn’t Turn Your Nose Up at Faecal Microbiota Transplantation

FAECAL microbiota transplantation (FMT) has been found to be an effective treatment for Clostridium difficile (C. diff) infection.

EMJ

Endosialin an Integral Cog in the Liver Fibrosis Machine

DISCOVERY of a new molecule on the surface of hepatic stellate cells has broadened knowledge of the underlying mechanisms that cause liver fibrosis…

EMJ

Plant Compounds Represent a Budding Option for Non-Alcoholic Fatty Liver Disease (NAFLD) Treatment

Plant compounds represent a budding option for Non-Alcoholic Fatty Liver Disease (NAFLD) treatment. Read the article and find out more

EMJ

From Insult to Injury: Possible Causes of Wound-Induced Skin Cancer

BACTERIA present on the skin may contribute to the development of wound-induced skin cancer according to the results of a new study…

EMJ

A New Era in the Treatment of Skin Cancer is at Hand. Literally.

WORLD Cancer Day 2015 saw the launch of a new free app for healthcare professionals, which has the potential to play a vital role in…

EMJ

ESMO 2014: The collaboration between basic scientists and clinicians

At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, UK) discusses how the increased interaction between basic scientists, clinicians…

EMJ

ESMO 2014: The TRACERx study of lung cancer

At ESMO 2014 Congress, Prof Charles Swanton (London Research Institute and UCL, UK) discusses TRAcking Cancer Evolution through therapy (TRACERx), which…

EMJ

ESMO 2014: Tumour evolution and precision medicine

At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, London, UK) discusses how understanding the genetic changes in tumour evolution…

EMJ

ESMO 2014: Tumour evolution and proactive clinical management

At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, London, UK) discusses how we can begin to anticipate tumour evolutionary…